Interdisciplinary Autoimmune Summit

Healio brings you the highlights from Interdisciplinary Autoimmune Summit. Refer back to this page often for the latest news from IAS, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting NewsVideo

VIDEO: What GIs can learn about IMIDs from other specialists

April 7, 2019
CHICAGO — In this exclusive video from the Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, medical director of the Digestive…
Meeting News

Nail enthesitis offers ‘gateway’ between appendicular system, skeletal PsA

April 7, 2019
CHICAGO — Nail enthesitis potentially offers an “intriguing gateway” connecting the appendicular system to the skeletal…
Meeting News

Patient satisfaction ‘highly correlated’ with treatment adherence

April 6, 2019
CHICAGO — Although rarely taken into account in practice guidelines, patient satisfaction remains an important factor in both treatment…
Meeting News

‘Medical home’ models must be patient-centered to improve experiences

April 6, 2019
CHICAGO — Advances in medical treatment, including the increased use of biologics, in recent years has led to a marked improvement in the…
Meeting News

Tips for transition from pediatric-to-adult care in chronic disease

April 6, 2019
CHICAGO — The transition from childhood to adulthood can be a big change for everyone, and that is no different for patients with chronic…
Meeting News

IAS keynote: Leadership titles mean little without ‘qualities of the leader’

April 6, 2019
CHICAGO — Leadership titles, whether they come in the form of “president,” “chief executive” or “dean,”…
Meeting News

Prednisone tapering fails in most patients with giant cell arteritis

April 5, 2019
CHICAGO — The majority of patients with giant cell arteritis who are treated with prednisone are unsuccessful in tapering the drug, unless…
Meeting News

Challenges remain, but microbiome may hold guide to inflammatory disease

April 5, 2019
CHICAGO — Inflammatory bowel disease is known as a prototype for new-age diseases. It grew out of industrializing countries a little more than…
Meeting News

Canakinumab ‘not ready for prime time’ in reducing CV mortality in patients with inflammation

April 5, 2019
CHICAGO — Although previous results from the CANTOS study have demonstrated that targeting inflammation could significantly improve…
Meeting News

Optimizing IBD therapies may depend on positioning, dosing, targeting new pathways

May 2, 2018
BOSTON – Given the numerous biologic pathways targeted by inflammation, the future development of new therapies for inflammatory bowel disease…